Guggenheim Capital’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RVMD
BBA
DGM
Guggenheim Capital's RVMD Position: Q3 2026 in Review
Guggenheim Capital reduced its Revolution Medicines (RVMD) stake by 11% in Q3 2026, selling an estimated $562K and leaving 23,641 shares worth $4.85M. The position accounts for 0.03% of the portfolio, ranked #441.
Guggenheim Capital first reported a position in RVMD in Q4 2023 and has held it in 12 quarters since. The position peaked at $4.96M in Q2 2026. 760 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.
- Guggenheim Capital held 23,641 shares of Revolution Medicines worth $4.85M as of Q3 2026.
- Guggenheim Capital sold 2,833 Revolution Medicines shares in Q3 2026, an estimated $562K.
- Revolution Medicines made up 0.03% of Guggenheim Capital's portfolio in Q3 2026, its #441 holding.
- Guggenheim Capital first reported a position in Revolution Medicines in Q4 2023 and has held it in 12 quarters since.
- Guggenheim Capital's Revolution Medicines position peaked at $4.96M in Q2 2026.
- 760 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.
Based on Guggenheim Capital's 13F filing for Q3 2026, filed 16 Nov 2026.